Teriparatide Trickles In For Richter
Forsteo Rival Posts Sales Of €4.8m Following Launches In August
Richter’s Terrosa biosimilar to Lilly’s Forsteo teriparatide brand made a modest start in Europe. But the Hungarian group still posted nine-month Pharmaceutical sales growth of 8.1%.
